Form 4: Carmen Chang of NeueHealth Acquires Warrants Following Agreement

Carmen Chang, a director of NeueHealth, acquired warrants to purchase common stock following a warrantholders agreement on April 8, 2024.

Summary

• On April 8, 2024, Carmen Chang, a director of NeueHealth, acquired warrants to purchase common stock.
• The warrants are related to a Warrantholders Agreement dated April 8, 2024, and an existing Credit Agreement.
• The warrants will be issued on the first business day following the conclusion of the 10 calendar day period after the distribution of the letter required to be mailed by the Issuer to its shareholders pursuant to Section 312.05 of the NYSE Listed Company Manual.
• The warrants are exercisable any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.
• The reporting person disclaims beneficial ownership of the securities held by NEA 16, NEA 17 and NEA 18 VGE in which the Reporting Person has no pecuniary interest.
• The warrants have an exercise price of $0.01.
• The total warrants acquired are 618,645.

Sentiment

Score: 7

Explanation: The document indicates a routine transaction related to warrant acquisition, which is neither overtly positive nor negative. The sentiment is neutral to slightly positive as it reflects ongoing investment in the company.

Future Outlook

The warrants are exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.

Industry Context

This filing reflects standard insider activity related to equity compensation and warrant agreements, common in publicly traded companies.

Stakeholder Impact

• The warrant issuance could potentially dilute existing shareholders if the warrants are exercised.

Next Steps

• Issuance of warrants following the conclusion of the 10 calendar day period after the distribution of the letter required to be mailed by the Issuer to its shareholders pursuant to Section 312.05 of the NYSE Listed Company Manual.

Key Dates